Selected research
Market Analysis & Forecast
Global Whole Genome Resequencing Service Market Analysis and Forecast 2026-2032
Market perspective
The global Whole Genome Resequencing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Whole Genome Resequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Whole Genome Resequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Whole Genome Resequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Whole Genome Resequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Whole Genome Resequencing Service include Macrogen, GENEWIZ, Eurofins Genomics, GATC Biotech, Otogenetics Corporation, SeqWright, Personalis Inc., Psomagen and Illumina, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Whole Genome Resequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Whole Genome Resequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Whole Genome Resequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Whole Genome Resequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Whole Genome Resequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Whole Genome Resequencing Service revenue, projected growth trends, production technology, application and end-user industry.
Whole Genome Resequencing Service Segment by Company
Macrogen
GENEWIZ
Eurofins Genomics
GATC Biotech
Otogenetics Corporation
SeqWright
Personalis Inc.
Psomagen
Illumina
BGI Genomics
Novogene
Whole Genome Resequencing Service Segment by Type
Human Whole Genome Resequencing
Animal Whole Genome Resequencing
Plant Whole Genome Resequencing
Whole Genome Resequencing Service Segment by Application
Evolutionary Studies
Molecule Breeding
Physiological Mechanism
Whole Genome Resequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Genome Resequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Genome Resequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Genome Resequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Whole Genome Resequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Whole Genome Resequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Genome Resequencing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Whole Genome Resequencing
- Animal Whole Genome Resequencing
- Plant Whole Genome Resequencing
Applications
- Evolutionary Studies
- Molecule Breeding
- Physiological Mechanism
Companies covered
- Macrogen
- GENEWIZ
- Eurofins Genomics
- GATC Biotech
- Otogenetics Corporation
- SeqWright
- Personalis Inc.
- Psomagen
- Illumina
- BGI Genomics
- Novogene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Whole Genome Resequencing Service Market by Type
- 1.2.1 Global Whole Genome Resequencing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Human Whole Genome Resequencing
- 1.2.3 Animal Whole Genome Resequencing
- 1.2.4 Plant Whole Genome Resequencing
- 1.3 Whole Genome Resequencing Service Market by Application
- 1.3.1 Global Whole Genome Resequencing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Evolutionary Studies
- 1.3.3 Molecule Breeding
- 1.3.4 Physiological Mechanism
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Whole Genome Resequencing Service Market Dynamics
- 2.1 Whole Genome Resequencing Service Industry Trends
- 2.2 Whole Genome Resequencing Service Industry Drivers
- 2.3 Whole Genome Resequencing Service Industry Opportunities and Challenges
- 2.4 Whole Genome Resequencing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Whole Genome Resequencing Service Market Perspective (2021-2032)
- 3.2 Global Whole Genome Resequencing Service Growth Trends by Region
- 3.2.1 Global Whole Genome Resequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Whole Genome Resequencing Service Market Size by Region (2021-2026)
- 3.2.3 Global Whole Genome Resequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Whole Genome Resequencing Service Revenue by Players
- 4.1.1 Global Whole Genome Resequencing Service Revenue by Players (2021-2026)
- 4.1.2 Global Whole Genome Resequencing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Whole Genome Resequencing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Whole Genome Resequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Whole Genome Resequencing Service Key Players Headquarters & Area Served
- 4.4 Global Whole Genome Resequencing Service Players, Product Type & Application
- 4.5 Global Whole Genome Resequencing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Whole Genome Resequencing Service Market CR5 and HHI
- 4.6.3 2025 Whole Genome Resequencing Service Tier 1, Tier 2, and Tier 3
5 Whole Genome Resequencing Service Market Size by Type
- 5.1 Global Whole Genome Resequencing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Whole Genome Resequencing Service Revenue by Type (2021-2032)
- 5.3 Global Whole Genome Resequencing Service Revenue Market Share by Type (2021-2032)
6 Whole Genome Resequencing Service Market Size by Application
- 6.1 Global Whole Genome Resequencing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Whole Genome Resequencing Service Revenue by Application (2021-2032)
- 6.3 Global Whole Genome Resequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Macrogen
- 7.1.1 Macrogen Company Information
- 7.1.2 Macrogen Business Overview
- 7.1.3 Macrogen Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Macrogen Whole Genome Resequencing Service Product Portfolio
- 7.1.5 Macrogen Recent Developments
- 7.2 GENEWIZ
- 7.2.1 GENEWIZ Company Information
- 7.2.2 GENEWIZ Business Overview
- 7.2.3 GENEWIZ Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 GENEWIZ Whole Genome Resequencing Service Product Portfolio
- 7.2.5 GENEWIZ Recent Developments
- 7.3 Eurofins Genomics
- 7.3.1 Eurofins Genomics Company Information
- 7.3.2 Eurofins Genomics Business Overview
- 7.3.3 Eurofins Genomics Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Eurofins Genomics Whole Genome Resequencing Service Product Portfolio
- 7.3.5 Eurofins Genomics Recent Developments
- 7.4 GATC Biotech
- 7.4.1 GATC Biotech Company Information
- 7.4.2 GATC Biotech Business Overview
- 7.4.3 GATC Biotech Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 GATC Biotech Whole Genome Resequencing Service Product Portfolio
- 7.4.5 GATC Biotech Recent Developments
- 7.5 Otogenetics Corporation
- 7.5.1 Otogenetics Corporation Company Information
- 7.5.2 Otogenetics Corporation Business Overview
- 7.5.3 Otogenetics Corporation Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Otogenetics Corporation Whole Genome Resequencing Service Product Portfolio
- 7.5.5 Otogenetics Corporation Recent Developments
- 7.6 SeqWright
- 7.6.1 SeqWright Company Information
- 7.6.2 SeqWright Business Overview
- 7.6.3 SeqWright Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 SeqWright Whole Genome Resequencing Service Product Portfolio
- 7.6.5 SeqWright Recent Developments
- 7.7 Personalis Inc.
- 7.7.1 Personalis Inc. Company Information
- 7.7.2 Personalis Inc. Business Overview
- 7.7.3 Personalis Inc. Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Personalis Inc. Whole Genome Resequencing Service Product Portfolio
- 7.7.5 Personalis Inc. Recent Developments
- 7.8 Psomagen
- 7.8.1 Psomagen Company Information
- 7.8.2 Psomagen Business Overview
- 7.8.3 Psomagen Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Psomagen Whole Genome Resequencing Service Product Portfolio
- 7.8.5 Psomagen Recent Developments
- 7.9 Illumina
- 7.9.1 Illumina Company Information
- 7.9.2 Illumina Business Overview
- 7.9.3 Illumina Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Illumina Whole Genome Resequencing Service Product Portfolio
- 7.9.5 Illumina Recent Developments
- 7.10 BGI Genomics
- 7.10.1 BGI Genomics Company Information
- 7.10.2 BGI Genomics Business Overview
- 7.10.3 BGI Genomics Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 BGI Genomics Whole Genome Resequencing Service Product Portfolio
- 7.10.5 BGI Genomics Recent Developments
- 7.11 Novogene
- 7.11.1 Novogene Company Information
- 7.11.2 Novogene Business Overview
- 7.11.3 Novogene Whole Genome Resequencing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Novogene Whole Genome Resequencing Service Product Portfolio
- 7.11.5 Novogene Recent Developments
8 North America
- 8.1 North America Whole Genome Resequencing Service Revenue (2021-2032)
- 8.2 North America Whole Genome Resequencing Service Revenue by Type (2021-2032)
- 8.2.1 North America Whole Genome Resequencing Service Revenue by Type (2021-2026)
- 8.2.2 North America Whole Genome Resequencing Service Revenue by Type (2027-2032)
- 8.3 North America Whole Genome Resequencing Service Revenue Share by Type (2021-2032)
- 8.4 North America Whole Genome Resequencing Service Revenue by Application (2021-2032)
- 8.4.1 North America Whole Genome Resequencing Service Revenue by Application (2021-2026)
- 8.4.2 North America Whole Genome Resequencing Service Revenue by Application (2027-2032)
- 8.5 North America Whole Genome Resequencing Service Revenue Share by Application (2021-2032)
- 8.6 North America Whole Genome Resequencing Service Revenue by Country
- 8.6.1 North America Whole Genome Resequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Whole Genome Resequencing Service Revenue by Country (2021-2026)
- 8.6.3 North America Whole Genome Resequencing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Whole Genome Resequencing Service Revenue (2021-2032)
- 9.2 Europe Whole Genome Resequencing Service Revenue by Type (2021-2032)
- 9.2.1 Europe Whole Genome Resequencing Service Revenue by Type (2021-2026)
- 9.2.2 Europe Whole Genome Resequencing Service Revenue by Type (2027-2032)
- 9.3 Europe Whole Genome Resequencing Service Revenue Share by Type (2021-2032)
- 9.4 Europe Whole Genome Resequencing Service Revenue by Application (2021-2032)
- 9.4.1 Europe Whole Genome Resequencing Service Revenue by Application (2021-2026)
- 9.4.2 Europe Whole Genome Resequencing Service Revenue by Application (2027-2032)
- 9.5 Europe Whole Genome Resequencing Service Revenue Share by Application (2021-2032)
- 9.6 Europe Whole Genome Resequencing Service Revenue by Country
- 9.6.1 Europe Whole Genome Resequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Whole Genome Resequencing Service Revenue by Country (2021-2026)
- 9.6.3 Europe Whole Genome Resequencing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Whole Genome Resequencing Service Revenue (2021-2032)
- 10.2 China Whole Genome Resequencing Service Revenue by Type (2021-2032)
- 10.2.1 China Whole Genome Resequencing Service Revenue by Type (2021-2026)
- 10.2.2 China Whole Genome Resequencing Service Revenue by Type (2027-2032)
- 10.3 China Whole Genome Resequencing Service Revenue Share by Type (2021-2032)
- 10.4 China Whole Genome Resequencing Service Revenue by Application (2021-2032)
- 10.4.1 China Whole Genome Resequencing Service Revenue by Application (2021-2026)
- 10.4.2 China Whole Genome Resequencing Service Revenue by Application (2027-2032)
- 10.5 China Whole Genome Resequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Whole Genome Resequencing Service Revenue (2021-2032)
- 11.2 Asia Whole Genome Resequencing Service Revenue by Type (2021-2032)
- 11.2.1 Asia Whole Genome Resequencing Service Revenue by Type (2021-2026)
- 11.2.2 Asia Whole Genome Resequencing Service Revenue by Type (2027-2032)
- 11.3 Asia Whole Genome Resequencing Service Revenue Share by Type (2021-2032)
- 11.4 Asia Whole Genome Resequencing Service Revenue by Application (2021-2032)
- 11.4.1 Asia Whole Genome Resequencing Service Revenue by Application (2021-2026)
- 11.4.2 Asia Whole Genome Resequencing Service Revenue by Application (2027-2032)
- 11.5 Asia Whole Genome Resequencing Service Revenue Share by Application (2021-2032)
- 11.6 Asia Whole Genome Resequencing Service Revenue by Country
- 11.6.1 Asia Whole Genome Resequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Whole Genome Resequencing Service Revenue by Country (2021-2026)
- 11.6.3 Asia Whole Genome Resequencing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Whole Genome Resequencing Service Revenue (2021-2032)
- 12.2 SAMEA Whole Genome Resequencing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Whole Genome Resequencing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Whole Genome Resequencing Service Revenue by Type (2027-2032)
- 12.3 SAMEA Whole Genome Resequencing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Whole Genome Resequencing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Whole Genome Resequencing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Whole Genome Resequencing Service Revenue by Application (2027-2032)
- 12.5 SAMEA Whole Genome Resequencing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Whole Genome Resequencing Service Revenue by Country
- 12.6.1 SAMEA Whole Genome Resequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Whole Genome Resequencing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Whole Genome Resequencing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst